{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Cat+Smith&min-dateTabled=2019-07-16", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Cat+Smith&min-dateTabled=2019-07-16", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Cat+Smith&min-dateTabled=2019-07-16&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Cat+Smith&_page=0&min-dateTabled=2019-07-16", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Cat+Smith&min-dateTabled=2019-07-16", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Cat+Smith&min-dateTabled=2019-07-16", "items" : [{"_about" : "http://data.parliament.uk/resources/1723266", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1723266/answer", "answerText" : {"_value" : "
The Foreign Secretary and Chancellor regularly discuss a wide range of issues. This Government is committed to restoring ODA spending at the level of 0.7 per cent of GNI as soon as fiscal circumstances allow and will set out its approach to the House in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4657", "label" : {"_value" : "Biography information for Anneliese Dodds"} } , "answeringMemberConstituency" : {"_value" : "Oxford East"} , "answeringMemberPrinted" : {"_value" : "Anneliese Dodds"} , "dateOfAnswer" : {"_value" : "2024-08-01", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-08-01T11:02:35.73Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2024-07-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Development Aid"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Office, pursuant to the Answer of 22 July 2024 to Question 210, whether he has had discussions with the Chancellor of the Exchequer on the fiscal circumstances within which the level of the Official Development Assistance budget will be raised to 0.7% of gross national income.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"} } , "tablingMemberConstituency" : {"_value" : "Lancaster and Wyre"} , "tablingMemberPrinted" : [{"_value" : "Cat Smith"} ], "uin" : "1508"} , {"_about" : "http://data.parliament.uk/resources/1722834", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1722834/answer", "answerText" : {"_value" : "
The consultation on the Modernising Support Green Paper closed on Monday 22 July. Over 16,000 responses have been received and we will review these responses.<\/p>
<\/p>
The proposals in this Green Paper were developed by the previous government. We will be considering our own approach to social security in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/163", "label" : {"_value" : "Biography information for Sir Stephen Timms"} } , "answeringMemberConstituency" : {"_value" : "East Ham"} , "answeringMemberPrinted" : {"_value" : "Sir Stephen Timms"} , "dateOfAnswer" : {"_value" : "2024-07-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-07-29T11:58:24.757Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "29"} , "answeringDeptShortName" : {"_value" : "Work and Pensions"} , "answeringDeptSortName" : {"_value" : "Work and Pensions"} , "date" : {"_value" : "2024-07-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Social Security Benefits: Disability"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Work and Pensions, when she plans to publish her Department's response to the consultation entitled Modernising support for independent living: the health and disability green paper, published in April 2024.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"} } , "tablingMemberConstituency" : {"_value" : "Lancaster and Wyre"} , "tablingMemberPrinted" : [{"_value" : "Cat Smith"} ], "uin" : "1285"} , {"_about" : "http://data.parliament.uk/resources/1722947", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1722947/answer", "answerText" : {"_value" : "
The Animals (Low Welfare Activities Abroad) Act 2023 provides a framework for the introduction of a future bans on the advertising and offering for sale, in England and Northern Ireland, of low-welfare animal activities abroad. Future decisions on the next steps will be evidence-based and subject to Parliamentary scrutiny.<\/p>
<\/p>
The Government will introduce the most ambitious programme for animal welfare in a generation. We are considering the most effective ways to deliver these commitments and will be setting out next steps in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"} } , "answeringMemberConstituency" : {"_value" : "Cambridge"} , "answeringMemberPrinted" : {"_value" : "Daniel Zeichner"} , "dateOfAnswer" : {"_value" : "2024-07-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-07-30T16:44:40.423Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "13"} , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"} , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"} , "date" : {"_value" : "2024-07-23", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Animal Welfare"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Environment, Food and Rural Affairs, whether his Department plans to launch a consultation on which activities should be banned from being (a) advertised and (b) offered for sale under the Animals (Low-Welfare Activities Abroad) Act 2023.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"} } , "tablingMemberConstituency" : {"_value" : "Lancaster and Wyre"} , "tablingMemberPrinted" : [{"_value" : "Cat Smith"} ], "uin" : "1286"} , {"_about" : "http://data.parliament.uk/resources/1721322", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1721322/answer", "answerText" : {"_value" : "
The emergency banning Order, restricting the sale or supply of puberty blockers, was introduced by the previous Government. The Order enables those who were already on a course of treatment with Gonadotrophin-Releasing Hormone Analogues, before 3 June 2024 from a UK based private or National Health Service provider, to continue to have them supplied. Those who were already on a course of treatment prescribed by an EEA or Switzerland registered prescriber can legally switch to a UK based prescriber to continue their treatment.<\/p>
The expert Cass Review, which is one of the most comprehensive reviews of gender identity services for children and young people to date, states that the rationale for early puberty suppressing hormones to treat gender dysphoria is unclear and the effects on cognitive and psychosexual development are unknown. This Government will always act in the interests of patient safety, which is why the Secretary of State signalled his intention to renew the Order and consult on a permanent ban (subject to the outcome of the ongoing judicial review).<\/p>
We are committed to implementing the recommendations of the Cass Review to ensure that young people presenting to the NHS with gender dysphoria are receiving appropriate and high-quality care. That is why NHS England and the National Institute of Health and Care Research, the research arm of the Department, are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.<\/p>
We will continue to monitor the impacts of the Order, including on mental health. Professor Louis Appleby, Chair of the National Suicide Prevention Strategy Advisory Group, has examined evidence for a large rise in suicides claimed by campaigners. His paper, which was published on 19 July 2024, concluded that the data do not support the claim that there has been a large rise in suicide in young gender dysphoria patients at the Tavistock clinic.<\/p>
Some children and young people may be concerned by these changes. If they are already under the care of a Children and Young People\u2019s mental health provider or the Child and Adolescent Mental Health Services, they can contact their team for advice. If they are not, their general practice team will be able to assess whether further referrals for mental health support are required. Patients can also be signposted to the advice on getting mental health support available on the NHS.UK website. Anyone in need of urgent support can contact NHS 111 and choose the mental health option, option two. Further details are available at the following link:<\/p>
https://www.nhs.uk/nhs-services/mental-health-services/where-to-get-urgent-help-for-mental-health/<\/a><\/p> Professor Appleby\u2019s paper is available at the following link:<\/p> https://www.gov.uk/government/publications/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust/review-of-suicides-and-gender-dysphoria-at-the-tavistock-and-portman-nhs-foundation-trust-independent-report<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
, "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
, "dateOfAnswer" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "109"}
, {"_value" : "91"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-07-29T13:55:40.377Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Gender Dysphoria: Children"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of restricting puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Lancaster and Wyre"}
, "tablingMemberPrinted" : [{"_value" : "Cat Smith"}
], "uin" : "87"}
, {"_about" : "http://data.parliament.uk/resources/1721323", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1721323/answer", "answerText" : {"_value" : " The emergency banning order limiting the sale or supply of puberty blockers against private or non-United Kingdom prescriptions allows a child under 18 years old, who was already on a course of treatment with Gonadotrophin-Releasing Hormone Analogues before 3 June 2024 from a UK based private or National Health Service provider, to continue to have them supplied. Those who were already on a course of treatment prescribed by an EEA or Switzerland registered prescriber can legally switch to a UK based prescriber to continue their treatment.<\/p> This government has committed to implementing the expert recommendations of the Cass Review to ensure that young people presenting to the NHS with gender dysphoria are receiving appropriate and high-quality care. That is why NHS England and the National Institue of Health and Care Research \u2013 the research arm of the department \u2013 are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.<\/p> Children and young people unable to access puberty blockers are strongly advised to meet with their clinician. We expect clinicians to be working with impacted patients to consider what the best care for them is going forward. Some children and young people may be concerned by these changes. If they are already under the care of a Children and Young People\u2019s mental health provider or the Child and Adolescent Mental Health Services, they can contact their team for advice. If they are not, their general practice team will be able to assess whether further referrals for mental health support are required. Patients can also be signposted to the advice on getting mental health support available on the NHS.UK website. Anyone in need of urgent support can contact NHS 111 and choose the mental health option, option two. Further details are available at the following link:<\/p> https://www.nhs.uk/nhs-services/mental-health-services/where-to-get-urgent-help-for-mental-health/<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "answeringMemberConstituency" : {"_value" : "Gorton and Denton"}
, "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"}
, "dateOfAnswer" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-07-29T14:33:23.927Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Gender Dysphoria: Children"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to ensure that those proscribed puberty blockers for the treatment of gender incongruence will continue to receive them.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Lancaster and Wyre"}
, "tablingMemberPrinted" : [{"_value" : "Cat Smith"}
], "uin" : "88"}
, {"_about" : "http://data.parliament.uk/resources/1721324", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1721324/answer", "answerText" : {"_value" : " The Cass Review is one of the most comprehensive reviews of gender identity services for children and young people to date worldwide.<\/p> The Cass review included an assessment of evidence from other countries and concluded that there was a lack of evidenced-based guidelines and, therefore, limitations for adopting these for National Health Service gender services. Informed by the Cass review, we are now reforming transgender care for young people in this country, based on the best possible evidence. That means a holistic approach, with puberty suppressing hormones only considered within a much broader needs assessment, and only then in the context of a clinical trial. We are committed to implementing the recommendations of the Cass Review, as that is the care model we believe to be the best approach in the interests of patient safety.<\/p> It is simply not possible for pharmacists to check whether prescriptions issued from overseas registered prescribers have been issued in a similarly safe and effective way, and we know that some overseas providers who advertise their services do not follow this approach.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
}
, "answeringMemberConstituency" : {"_value" : "Bristol South"}
, "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
, "dateOfAnswer" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-07-29T14:25:58.313Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Gender Dysphoria: Children"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department has made a comparative assessment of the UK\u2019s position on the prescription of puberty blockers for the treatment of gender incongruence with that of other European countries.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Lancaster and Wyre"}
, "tablingMemberPrinted" : [{"_value" : "Cat Smith"}
], "uin" : "89"}
, {"_about" : "http://data.parliament.uk/resources/1721325", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1721325/answer", "answerText" : {"_value" : " The expert Cass Review, which is one of the most comprehensive reviews of gender identity services for children and young people to date, states that the rationale for early puberty suppressing hormones to treat gender dysphoria is unclear and the effects on cognitive and psychosexual development are unknown. This is why NHS England and the National Institute of Health and Care Research, the research arm of the department, are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4444", "label" : {"_value" : "Biography information for Karin Smyth"}
}
, "answeringMemberConstituency" : {"_value" : "Bristol South"}
, "answeringMemberPrinted" : {"_value" : "Karin Smyth"}
, "dateOfAnswer" : {"_value" : "2024-07-29", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "443"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-07-29T14:21:24.147Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-07-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Gender Dysphoria: Children"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what his timetable is for the clinical trial being conducted on the use of puberty blockers for the treatment of gender incongruence.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"}
}
, "tablingMemberConstituency" : {"_value" : "Lancaster and Wyre"}
, "tablingMemberPrinted" : [{"_value" : "Cat Smith"}
], "uin" : "90"}
, {"_about" : "http://data.parliament.uk/resources/1721326", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1721326/answer", "answerText" : {"_value" : " The emergency banning Order, restricting the sale or supply of puberty blockers, was introduced by the previous Government. The Order enables those who were already on a course of treatment with Gonadotrophin-Releasing Hormone Analogues, before 3 June 2024 from a UK based private or National Health Service provider, to continue to have them supplied. Those who were already on a course of treatment prescribed by an EEA or Switzerland registered prescriber can legally switch to a UK based prescriber to continue their treatment.<\/p> The expert Cass Review, which is one of the most comprehensive reviews of gender identity services for children and young people to date, states that the rationale for early puberty suppressing hormones to treat gender dysphoria is unclear and the effects on cognitive and psychosexual development are unknown. This Government will always act in the interests of patient safety, which is why the Secretary of State signalled his intention to renew the Order and consult on a permanent ban (subject to the outcome of the ongoing judicial review).<\/p> We are committed to implementing the recommendations of the Cass Review to ensure that young people presenting to the NHS with gender dysphoria are receiving appropriate and high-quality care. That is why NHS England and the National Institute of Health and Care Research, the research arm of the Department, are working together to commission a study into the potential benefits and harms of puberty suppressing hormones as a treatment option for children and young people with gender incongruence. The study team is now in place and are finalising their application for funding which will be assessed by an independent scientific review study ahead of the commencement of wider approvals, including ethics, and set up.<\/p> We will continue to monitor the impacts of the Order, including on mental health. Professor Louis Appleby, Chair of the National Suicide Prevention Strategy Advisory Group, has examined evidence for a large rise in suicides claimed by campaigners. His paper, which was published on 19 July 2024, concluded that the data do not support the claim that there has been a large rise in suicide in young gender dysphoria patients at the Tavistock clinic.<\/p> Some children and young people may be concerned by these changes. If they are already under the care of a Children and Young People\u2019s mental health provider or the Child and Adolescent Mental Health Services, they can contact their team for advice. If they are not, their general practice team will be able to assess whether further referrals for mental health support are required. Patients can also be signposted to the advice on getting mental health support available on the NHS.UK website. Anyone in need of urgent support can contact NHS 111 and choose the mental health option, option two. Further details are available at the following link:<\/p>